Skip to main content

previous disabled Page of 7
and
  1. Article

    Open Access

    A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results

    Spinal muscular atrophy (SMA) is a rare, autosomal recessive, neuromuscular disease that leads to progressive muscular weakness and atrophy. Nusinersen, an antisense oligonucleotide, was approved for SMA in Ch...

    Yuwu Jiang, Yi Wang, Hui **ong, Wenhui Li, Rong Luo, Wenxiong Chen in Advances in Therapy (2024)

  2. No Access

    Article

    Correlation Between Coronal Position Sequence of Lumbar and WOMAC Score in Knee Osteoarthritis (KOA) in Standard Standing Position

    Sagittal sequences of the spine have been shown to correlate with knee osteoarthritis (KOA), but coronal sequences and KOA have never been studied before. The study required patients to use a standard standing...

    Peiyu Du, Yuntao Yan, Shilin Yin, ** Li, Hui Wang, Jiayuan Sun in Advances in Therapy (2024)

  3. No Access

    Article

    Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis

    Stapokibart, a novel humanized anti-interleukin (IL)-4 receptor alpha monoclonal antibody, inhibits the signaling of IL-4 and IL-13, which are key drivers of type 2 inflammation in atopic dermatitis (AD). This...

    Libo Zhang, Weilong Zhang, Yufeng Xu, Lihou Dong, Yunjuan Sun in Advances in Therapy (2024)

  4. No Access

    Article

    Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China

    Adding finerenone to current standard of care (SoC), as recommended by Chinese guidelines, has shown substantial benefit in delaying chronic kidney disease (CKD) progression and reducing cardiovascular risk in...

    Jian Ming, Guanqi Hong, Yingrui Xu, Paul Mernagh, Michał Pochopień in Advances in Therapy (2024)

  5. No Access

    Article

    Imaging-Guided Percutaneous Endovascular Biopsy Applied in Patients with Pulmonary Artery Masses: A Review

    Pulmonary artery (PA) masses are rare. Distinguishing PA tumours from embolism is sometimes difficult, and surgical biopsy is expensive and risky. We aimed to evaluate the efficacy of imaging-guided percutaneo...

    Hongxia Wu, Kaiquan Zhuo, Li Guo, Faming Jiang, Bo Zhang, Ye Wang in Advances in Therapy (2024)

  6. No Access

    Article

    Endovenous Microwave Ablation Versus Laser Ablation for Small Saphenous Vein Varicosis

    Laser and radiofrequency ablation are two thermal ablation methods currently widely used to treat lower limb venous insufficiency. However, very few studies have been conducted on the use of microwaves, a form...

    Weiqin Lu, **song Jiang, Hao Wu, Guangde Chen, Qinguo Zhang in Advances in Therapy (2024)

  7. No Access

    Article

    Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis

    Allergen-specific immunotherapy (AIT) plays a pivotal role in altering the immune status and tissue responses in allergic rhinitis (AR). This study focuses on the impact of sublingual immunotherapy (SLIT) invo...

    Yue Pan, **nxin Zhang, Huanting Geng, Yan Yu, Jianyong Liu in Advances in Therapy (2024)

  8. No Access

    Article

    Cost-Effectiveness Analysis of Sintilimab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: A Societal Perspective

    The updated ORIENT-11 study demonstrated that sintilimab, when combined with chemotherapy, had promising survival advantage compared to standard chemotherapy alone in the first-line treatment for previously un...

    Fuming Li, Yingyao Chen, Dunming **ao, Shan Jiang, Yi Yang in Advances in Therapy (2024)

  9. Article

    Open Access

    Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

    Systemic therapies have been associated with clinically significant events (CSEs) in patients with unresectable hepatocellular carcinoma (uHCC). We evaluated the incidence of CSEs (bleeding, clotting, encephal...

    Daniel J. Simmons, Stephen J. Valerio, Darren S. Thomas in Advances in Therapy (2024)

  10. No Access

    Article

    Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study

    Antibody–drug conjugate (ADC) and programmed death-1 (PD-1) inhibitors play crucial roles in the treatment of advanced urothelial cancer (aUC). Increasingly, combination treatment modalities are used in patien...

    Hongfan Zhao, Zhicheng Xu, Chengbin Li, Tong Xu, **gliang Zhang in Advances in Therapy (2024)

  11. Article

    Open Access

    Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study

    Insights into real-world treatment of atopic dermatitis (AD) are relevant to clinical decision making. The aim of this analysis was to characterize patients who receive dupilumab for AD in a real-world setting.

    Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere in Advances in Therapy (2023)

  12. No Access

    Article

    Biomarkers-Based Cost-Effectiveness of Toripalimab Plus Chemotherapy for Patients with Treatment-Naive Advanced Non-Small Cell Lung Cancer

    This study examined the cost-effectiveness of first-line toripalimab plus chemotherapy (TC) for patients with advanced non-small cell lung cancer (NSCLC), excluding patients with nonsquamous NSCLC and EGFR/ALK mu...

    Huixian Zhang, Lanfang Li, Lei Feng, Zhen Zhou, **n Zhang in Advances in Therapy (2023)

  13. Article

    Open Access

    Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis

    Spinal muscular atrophy (SMA) is a neurogenic disorder associated with progressive loss of muscle function, respiratory failure, and premature mortality. This study aimed to describe and compare real-world hea...

    Walter Toro, Min Yang, Mihaela Georgieva, Wei Song, Anish Patel in Advances in Therapy (2023)

  14. Article

    Open Access

    Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke

    This study aims to assess the risk of direct oral anticoagulant (DOAC) discontinuation among Medicare beneficiaries with non-valvular atrial fibrillation (NVAF) who reach the Medicare coverage gap stratified b...

    Tabassum Salam, Urvi Desai, Patrick Lefebvre, E Jian-Yu in Advances in Therapy (2023)

  15. Article

    Open Access

    Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China

    Tyrosine-kinase inhibitors (TKIs) have become the standard treatment for patients with advanced gastrointestinal stromal tumor (GIST); however, secondary mutations can still drive disease progression. Studies ...

    **nhua Zhang, Peng Zhang, Haibo Qiu, Yong Fang, Heli Liu in Advances in Therapy (2023)

  16. Article

    Open Access

    A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy

    In the absence of head-to-head trials, indirect treatment comparisons (ITCs) are often used to compare the efficacy of different therapies to support decision-making. Matching-adjusted indirect comparison (MAI...

    Tammy Jiang, Bora Youn, Angela D. Paradis, Rachel Beckerman in Advances in Therapy (2023)

  17. Article

    Open Access

    Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

    Pembrolizumab was approved in the US as adjuvant treatment of patients with stage IIB or IIC melanoma post-complete resection, based on prolonged recurrence-free survival vs. placebo in the Phase 3 KEYNOTE-716...

    Shu**g Zhang, Arielle G. Bensimon, Ruifeng Xu, Ruixuan Jiang in Advances in Therapy (2023)

  18. Article

    Open Access

    Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study

    Kukoamine B (KB) is a novel sepsis therapeutic drug targeting lipopolysaccharide and CpG DNA. This study aims to evaluate the safety, tolerability, and pharmacokinetic (PK) profile of multiple doses of KB in h...

    Qian Zhao, Hongzhong Liu, Zhenlei Wang, Teng Wang, Cheng Cui in Advances in Therapy (2023)

  19. Article

    Open Access

    Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection

    The KEYNOTE-054 trial found that adjuvant treatment with pembrolizumab improved recurrence-free survival versus placebo in completely resected high-risk stage III melanoma patients. We assessed the cost-effect...

    Cesar Lopez-Vinueza, Juan Urrego-Reyes, Fredy R. S. Gutierrez in Advances in Therapy (2023)

  20. No Access

    Article

    Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers

    Lung cancer is one of the most common cancer malignancies and the principal cause of cancer-associated deaths worldwide. Non-small cell lung cancers (NSCLCs) account for more than 80% of all lung cancer cases....

    Yu Huang, Dong-Ming Guo, Shi Bu, Wei Xu, Qing-Chun Cai, Jian Xu in Advances in Therapy (2023)

previous disabled Page of 7